Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » BioDiem Half Year Financial report
BioDiem Half Year Financial report
March 16, 2015 •
Category
•
Author Name
BioDiem Half Year Financial report
Latest News
BioDiem Update and EOFY Information
July 4, 2024
24-07-04 BioDiem Update and EOFY information
Read More
Results of GM
April 19, 2024
View Results of AGM
Read More